CN103772576B - 一种应用于普那霉素分离的吸附剂的制备方法 - Google Patents
一种应用于普那霉素分离的吸附剂的制备方法 Download PDFInfo
- Publication number
- CN103772576B CN103772576B CN201410035287.1A CN201410035287A CN103772576B CN 103772576 B CN103772576 B CN 103772576B CN 201410035287 A CN201410035287 A CN 201410035287A CN 103772576 B CN103772576 B CN 103772576B
- Authority
- CN
- China
- Prior art keywords
- vinylformic acid
- pristinamycin
- preparation
- pore
- pyridine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010079780 Pristinamycin Proteins 0.000 title claims abstract description 33
- RLNUPSVMIYRZSM-UHFFFAOYSA-N Pristinamycin Natural products CC1OC(=O)C(C=2C=CC=CC=2)NC(=O)C2CC(=O)CCN2C(=O)C(CC=2C=CC(=CC=2)N(C)C)CCN(C)C(=O)C2CCCN2C(=O)C(CC)NC(=O)C1NC(=O)C1=NC=CC=C1O RLNUPSVMIYRZSM-UHFFFAOYSA-N 0.000 title claims abstract description 33
- 229960003961 pristinamycin Drugs 0.000 title claims abstract description 33
- DAIKHDNSXMZDCU-OUDXUNEISA-N pristinamycin-IIA Natural products CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c3coc(CC(=O)C[C@H](O)C=C(C)C=CCNC(=O)C=C[C@@H]1C)n3 DAIKHDNSXMZDCU-OUDXUNEISA-N 0.000 title claims abstract description 33
- JOOMGSFOCRDAHL-XKCHLWDXSA-N pristinamycin-IIB Natural products CC(C)[C@@H]1OC(=O)[C@H]2CCCN2C(=O)c3coc(CC(=O)C[C@@H](O)C=C(C)C=CCNC(=O)C=C[C@H]1C)n3 JOOMGSFOCRDAHL-XKCHLWDXSA-N 0.000 title claims abstract description 33
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000002594 sorbent Substances 0.000 title claims abstract description 10
- YVMBAUWDIGJRNY-BESUKNQGSA-N 4o8o7q7iu4 Chemical compound C1C(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@@H](C)[C@@H](C(C)C)OC(=O)C2=CCCN2C(=O)C2=COC1=N2.N([C@@H]1C(=O)N[C@@H](C(N2CCC[C@H]2C(=O)N(C)[C@@H](CC=2C=CC(=CC=2)N(C)C)C(=O)N2CCC(=O)C[C@H]2C(=O)N[C@H](C(=O)O[C@@H]1C)C=1C=CC=CC=1)=O)CC)C(=O)C1=NC=CC=C1O YVMBAUWDIGJRNY-BESUKNQGSA-N 0.000 title claims abstract 3
- 238000006243 chemical reaction Methods 0.000 claims abstract description 25
- 239000003795 chemical substances by application Substances 0.000 claims abstract description 16
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 12
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 claims abstract description 5
- 239000003999 initiator Substances 0.000 claims abstract description 5
- 239000006185 dispersion Substances 0.000 claims abstract description 4
- 239000012071 phase Substances 0.000 claims description 13
- 239000008346 aqueous phase Substances 0.000 claims description 10
- 238000003756 stirring Methods 0.000 claims description 10
- 238000007664 blowing Methods 0.000 claims description 8
- 238000005406 washing Methods 0.000 claims description 7
- 238000010557 suspension polymerization reaction Methods 0.000 claims description 5
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000004372 Polyvinyl alcohol Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- 150000002978 peroxides Chemical class 0.000 claims description 3
- 229920002451 polyvinyl alcohol Polymers 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- XZKRXPZXQLARHH-UHFFFAOYSA-N buta-1,3-dienylbenzene Chemical compound C=CC=CC1=CC=CC=C1 XZKRXPZXQLARHH-UHFFFAOYSA-N 0.000 claims description 2
- 239000002270 dispersing agent Substances 0.000 claims description 2
- 239000011347 resin Substances 0.000 abstract description 11
- 229920005989 resin Polymers 0.000 abstract description 11
- ZAHRKKWIAAJSAO-UHFFFAOYSA-N rapamycin Natural products COCC(O)C(=C/C(C)C(=O)CC(OC(=O)C1CCCCN1C(=O)C(=O)C2(O)OC(CC(OC)C(=CC=CC=CC(C)CC(C)C(=O)C)C)CCC2C)C(C)CC3CCC(O)C(C3)OC)C ZAHRKKWIAAJSAO-UHFFFAOYSA-N 0.000 abstract description 6
- QFJCIRLUMZQUOT-HPLJOQBZSA-N sirolimus Chemical compound C1C[C@@H](O)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 QFJCIRLUMZQUOT-HPLJOQBZSA-N 0.000 abstract description 6
- 229960002930 sirolimus Drugs 0.000 abstract description 6
- 239000003513 alkali Substances 0.000 abstract description 4
- 239000002253 acid Substances 0.000 abstract description 3
- 238000005260 corrosion Methods 0.000 abstract description 3
- 230000007797 corrosion Effects 0.000 abstract description 3
- 239000011159 matrix material Substances 0.000 abstract description 3
- 239000000178 monomer Substances 0.000 abstract description 3
- 238000006116 polymerization reaction Methods 0.000 abstract description 3
- 239000004971 Cross linker Substances 0.000 abstract description 2
- 238000010792 warming Methods 0.000 abstract description 2
- MVTQIFVKRXBCHS-SMMNFGSLSA-N N-[(3S,6S,12R,15S,16R,19S,22S)-3-benzyl-12-ethyl-4,16-dimethyl-2,5,11,14,18,21,24-heptaoxo-19-phenyl-17-oxa-1,4,10,13,20-pentazatricyclo[20.4.0.06,10]hexacosan-15-yl]-3-hydroxypyridine-2-carboxamide (10R,11R,12E,17E,19E,21S)-21-hydroxy-11,19-dimethyl-10-propan-2-yl-9,26-dioxa-3,15,28-triazatricyclo[23.2.1.03,7]octacosa-1(27),6,12,17,19,25(28)-hexaene-2,8,14,23-tetrone Chemical compound CC(C)[C@H]1OC(=O)C2=CCCN2C(=O)c2coc(CC(=O)C[C@H](O)\C=C(/C)\C=C\CNC(=O)\C=C\[C@H]1C)n2.CC[C@H]1NC(=O)[C@@H](NC(=O)c2ncccc2O)[C@@H](C)OC(=O)[C@@H](NC(=O)[C@@H]2CC(=O)CCN2C(=O)[C@H](Cc2ccccc2)N(C)C(=O)[C@@H]2CCCN2C1=O)c1ccccc1 MVTQIFVKRXBCHS-SMMNFGSLSA-N 0.000 description 34
- 239000000047 product Substances 0.000 description 15
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 13
- 238000000034 method Methods 0.000 description 9
- 239000000706 filtrate Substances 0.000 description 8
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 4
- 239000012043 crude product Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 241001655322 Streptomycetales Species 0.000 description 3
- 239000003463 adsorbent Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000000605 extraction Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 0 **=*c1ccncc1 Chemical compound **=*c1ccncc1 0.000 description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 2
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000000274 adsorptive effect Effects 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 238000011031 large-scale manufacturing process Methods 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- IOLCXVTUBQKXJR-UHFFFAOYSA-M potassium bromide Chemical compound [K+].[Br-] IOLCXVTUBQKXJR-UHFFFAOYSA-M 0.000 description 2
- SSAYTINUCCRGDR-OWOJBTEDSA-N (e)-3-pyridin-4-ylprop-2-enoic acid Chemical group OC(=O)\C=C\C1=CC=NC=C1 SSAYTINUCCRGDR-OWOJBTEDSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- BRARRAHGNDUELT-UHFFFAOYSA-N 3-hydroxypicolinic acid Chemical group OC(=O)C1=NC=CC=C1O BRARRAHGNDUELT-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000004342 Benzoyl peroxide Substances 0.000 description 1
- OMPJBNCRMGITSC-UHFFFAOYSA-N Benzoylperoxide Chemical compound C=1C=CC=CC=1C(=O)OOC(=O)C1=CC=CC=C1 OMPJBNCRMGITSC-UHFFFAOYSA-N 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical class OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- 108010034396 Streptogramins Proteins 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 description 1
- 125000000539 amino acid group Chemical group 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000019400 benzoyl peroxide Nutrition 0.000 description 1
- 229940000635 beta-alanine Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000007334 copolymerization reaction Methods 0.000 description 1
- 238000004132 cross linking Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- SUYRLXYYZQTJHF-VMBLUXKRSA-N dalfopristin Chemical compound O=C([C@@H]1N(C2=O)CC[C@H]1S(=O)(=O)CCN(CC)CC)O[C@H](C(C)C)[C@H](C)\C=C\C(=O)NC\C=C\C(\C)=C\[C@@H](O)CC(=O)CC1=NC2=CO1 SUYRLXYYZQTJHF-VMBLUXKRSA-N 0.000 description 1
- 229960002615 dalfopristin Drugs 0.000 description 1
- 108700028430 dalfopristin Proteins 0.000 description 1
- 239000003480 eluent Substances 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000002070 germicidal effect Effects 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 150000007931 macrolactones Chemical class 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000001728 nano-filtration Methods 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001374 post-anti-biotic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007670 refining Methods 0.000 description 1
- 238000001179 sorption measurement Methods 0.000 description 1
- 229960002898 threonine Drugs 0.000 description 1
Landscapes
- Solid-Sorbent Or Filter-Aiding Compositions (AREA)
Abstract
Description
产品编号 | 收率% |
W-1 | 78 |
W-2 | 73 |
W-3 | 81 |
W-4 | 84 |
W-5 | 75 |
W-6 | 84 |
W-7 | 77 |
W-8 | 62 |
W-9 | 60 |
W-10 | 48 |
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410035287.1A CN103772576B (zh) | 2014-01-22 | 2014-01-22 | 一种应用于普那霉素分离的吸附剂的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410035287.1A CN103772576B (zh) | 2014-01-22 | 2014-01-22 | 一种应用于普那霉素分离的吸附剂的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103772576A CN103772576A (zh) | 2014-05-07 |
CN103772576B true CN103772576B (zh) | 2016-03-09 |
Family
ID=50565382
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410035287.1A Active CN103772576B (zh) | 2014-01-22 | 2014-01-22 | 一种应用于普那霉素分离的吸附剂的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103772576B (zh) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105294910B (zh) * | 2015-11-30 | 2018-04-03 | 王金明 | 一种应用于普那霉素分离的吸附剂的制备方法 |
CN106065042B (zh) * | 2015-12-18 | 2018-08-07 | 王金明 | 一种肝素钠专用吸附剂的制备 |
CN106040206A (zh) * | 2016-07-28 | 2016-10-26 | 王金明 | 一种四氯化碳提纯用吸附剂的制备方法 |
CN106238009A (zh) * | 2016-07-28 | 2016-12-21 | 王金明 | 一种四氯化碳吸附剂的制备方法 |
CN106179276A (zh) * | 2016-08-21 | 2016-12-07 | 王金桢 | 一种锗烷提纯用吸附剂的制备方法 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3154475A (en) * | 1961-06-27 | 1964-10-27 | Rhone Poulenc Sa | Process for the production of pristinamycin |
GB998195A (en) * | 1961-06-27 | 1965-07-14 | Rhone Poulenc Sa | Process for the production of an antibiotic |
CN102465164A (zh) * | 2010-11-10 | 2012-05-23 | 华北制药集团新药研究开发有限责任公司 | 普那霉素的制备方法 |
-
2014
- 2014-01-22 CN CN201410035287.1A patent/CN103772576B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3154475A (en) * | 1961-06-27 | 1964-10-27 | Rhone Poulenc Sa | Process for the production of pristinamycin |
GB998195A (en) * | 1961-06-27 | 1965-07-14 | Rhone Poulenc Sa | Process for the production of an antibiotic |
CN102465164A (zh) * | 2010-11-10 | 2012-05-23 | 华北制药集团新药研究开发有限责任公司 | 普那霉素的制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN103772576A (zh) | 2014-05-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105294910A (zh) | 一种应用于普那霉素分离的吸附剂的制备方法 | |
CN103772576B (zh) | 一种应用于普那霉素分离的吸附剂的制备方法 | |
CN105597711B (zh) | 一种二元酸精制的吸附材料的制备方法 | |
CN101792461B (zh) | 一种注射用大豆卵磷脂的制备工艺 | |
CN103752288B (zh) | 一种应用于雷帕霉素分离的吸附剂的制备方法 | |
CN100595225C (zh) | 分子印迹聚合物微球的制备方法及其分离恩诺沙星的方法 | |
CN102898566B (zh) | 一种富集痕量速灭威的金属有机框架分子印迹聚合物的制备方法 | |
CN109092265A (zh) | 一种聚咪唑离子液体改性的纤维素基吸附剂及其制备方法和应用 | |
CN101863946A (zh) | 一种从干罗汉果中提取高含量罗汉果甜甙v的方法 | |
CN102600813B (zh) | 一种丝瓜络表面青蒿素分子印迹吸附材料的制备方法及应用 | |
CN101092490A (zh) | 氨苄青霉素分子印迹聚合物微球的制备方法 | |
Ma et al. | Solanesol extraction from tobacco leaves by Flash chromatography based on molecularly imprinted polymers | |
CN104014313A (zh) | 一种改性麦壳吸附剂 | |
CN104861007A (zh) | 一种利用树脂吸附发酵原液提取林可霉素的方法 | |
CN108929408A (zh) | 一种甜菊糖印迹材料的制备方法及应用 | |
CN112694564A (zh) | 一种糠醛类分子印迹聚合物的制备方法与应用 | |
CN106046254B (zh) | 富集京尼平苷的亲水性分子印迹聚合物及制备方法和应用 | |
CN102503804B (zh) | 一种活性炭对丁二酸发酵液进行连续脱色的方法 | |
CN111393568B (zh) | 生育酚分子印迹聚合物及制备方法和应用 | |
CN102382252A (zh) | 辣椒碱分子印迹聚合物及其制备方法 | |
CN101914066B (zh) | 利用分子印迹聚合物净化和检测抗蚜威的方法 | |
CN104311616A (zh) | 一种从秦皮中提取高纯度秦皮甲素和秦皮苷的方法 | |
CN111574347A (zh) | 一种从茉莉花渣中提取茉莉酮和茉莉内酯的分子印迹方法 | |
CN105085827A (zh) | 一种丹参素表面分子印迹聚合物的制备方法 | |
CN105289545B (zh) | 一种雷帕霉素分离用吸附剂的制备 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200306 Address after: Ganquan road Shushan District of Hefei City, Anhui Province, 230000 West hillock road to the South Wild Garden commercial office building room B-1512 Patentee after: Anhui Eagle Dragon Industrial Design Co., Ltd. Address before: 322000 Zhejiang province Yiwu City Binwang zipper Street 5 District No. 3 room 602 Patentee before: Wang Jinming |
|
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20201116 Address after: Group 17, Jianghai village, Binhai New Area (jiaoxie town), laobagang, Hai'an City, Nantong City, Jiangsu Province 226600 Patentee after: Nantong Binrui Intelligent Technology Co.,Ltd. Address before: Ganquan road Shushan District of Hefei City, Anhui Province, 230000 West hillock road to the South Wild Garden commercial office building room B-1512 Patentee before: ANHUI YINGLONG INDUSTRIAL DESIGN Co.,Ltd. |